Zigui Chen

801 total citations · 1 hit paper
24 papers, 456 citations indexed

About

Zigui Chen is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zigui Chen has authored 24 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zigui Chen's work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Extracellular vesicles in disease (5 papers). Zigui Chen is often cited by papers focused on MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (7 papers) and Extracellular vesicles in disease (5 papers). Zigui Chen collaborates with scholars based in China. Zigui Chen's co-authors include Jiale Li, Quan Cheng, Renjun Peng, Bing Jiang, Bing‐Hua Jiang, Xin Wan, Zhiming Ma, Rui Chen, Shuiqing Wu and Juan Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Zigui Chen

21 papers receiving 451 citations

Hit Papers

Emerging role of exosomes in cancer therapy: progress and... 2025 2026 2025 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zigui Chen China 13 313 190 43 38 38 24 456
Yakun Liu China 13 325 1.0× 128 0.7× 31 0.7× 34 0.9× 31 0.8× 36 443
Xiwei Xia China 11 489 1.6× 415 2.2× 43 1.0× 46 1.2× 16 0.4× 11 657
Shaohong Cheng United States 14 278 0.9× 92 0.5× 52 1.2× 52 1.4× 10 0.3× 19 410
Mauro Savino Italy 10 342 1.1× 157 0.8× 92 2.1× 11 0.3× 26 0.7× 11 431
Elliot Surgenor Australia 7 497 1.6× 67 0.4× 120 2.8× 26 0.7× 23 0.6× 9 668
Chiara Tobia Italy 12 284 0.9× 91 0.5× 40 0.9× 29 0.8× 13 0.3× 25 445
Suna Önengüt United States 11 396 1.3× 88 0.5× 71 1.7× 34 0.9× 7 0.2× 11 551
Jianbo He China 13 304 1.0× 53 0.3× 60 1.4× 68 1.8× 30 0.8× 32 696

Countries citing papers authored by Zigui Chen

Since Specialization
Citations

This map shows the geographic impact of Zigui Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zigui Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zigui Chen more than expected).

Fields of papers citing papers by Zigui Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zigui Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zigui Chen. The network helps show where Zigui Chen may publish in the future.

Co-authorship network of co-authors of Zigui Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zigui Chen. A scholar is included among the top collaborators of Zigui Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zigui Chen. Zigui Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Haijun, Wei Zheng, Rui Chen, et al.. (2025). Exosomes: innovative biomarkers leading the charge in non-invasive cancer diagnostics. Theranostics. 15(11). 5277–5311. 9 indexed citations
2.
Chen, Zigui, He Zhang, Jiawei Luo, et al.. (2025). Olfactory mucosa-mesenchymal stem cells with overexpressed Nrf2 modulate angiogenesis and exert anti-inflammation effect in an in vitro traumatic brain injury model. European journal of medical research. 30(1). 80–80. 4 indexed citations
3.
Li, Jiale, et al.. (2025). Emerging role of exosomes in cancer therapy: progress and challenges. Molecular Cancer. 24(1). 13–13. 93 indexed citations breakdown →
4.
Peng, Jun, et al.. (2025). The Dual Role of Exosomes in the Tumor Microenvironment: From Pro‐Tumorigenic Signaling to Immune Modulation. SHILAP Revista de lepidopterología. 1(2). 257–284. 3 indexed citations
5.
Li, Jiale, et al.. (2025). Exosome-based liquid biopsy: A new frontier in early cancer diagnosis. BioScience Trends. 19(5). 589–593.
6.
Chen, Zigui, Chao Liu, Wei Zheng, et al.. (2025). MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway. Scientific Reports. 15(1). 4618–4618. 1 indexed citations
7.
Chen, Zigui, Chao Liu, Weihao Zheng, et al.. (2024). Deciphering the Role of SLFN12: A Novel Biomarker for Predicting Immunotherapy Outcomes in Glioma Patients Through Artificial Intelligence. Journal of Cellular and Molecular Medicine. 28(24). e70317–e70317.
8.
Chen, Zigui, et al.. (2024). Machine learning-based discovery of UPP1 as a key oncogene in tumorigenesis and immune escape in gliomas. Frontiers in Immunology. 15. 1475206–1475206.
9.
Chen, Zigui, Dandan Zheng, Chunyuan Zhang, et al.. (2023). GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses. Frontiers in Immunology. 14. 1260169–1260169. 6 indexed citations
10.
Luo, Qisheng, Junhong Zhuang, Dandan Zheng, et al.. (2023). IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy. Frontiers in Immunology. 14. 1282734–1282734. 5 indexed citations
11.
Chen, Zigui, et al.. (2023). Targeting MYH9 represses USP14-mediated NAP1L1 deubiquitination and cell proliferation in glioma. Cancer Cell International. 23(1). 220–220. 9 indexed citations
12.
Xie, Yingying, et al.. (2022). NAP1L1 promotes tumor proliferation through HDGF/C-JUN signaling in ovarian cancer. BMC Cancer. 22(1). 339–339. 17 indexed citations
13.
Chen, Rui, Huan Liu, Quan Cheng, et al.. (2016). MicroRNA-93 promotes the malignant phenotypes of human glioma cells and induces their chemoresistance to temozolomide. Biology Open. 5(6). 669–677. 25 indexed citations
14.
Xia, Zhiwei, Xiaoming Liu, Junyu Wang, et al.. (2016). Coiling Is Not Superior to Clipping in Patients with High-Grade Aneurysmal Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis. World Neurosurgery. 98. 411–420. 31 indexed citations
15.
Cheng, Quan, Richard Ma, Hui Cao, et al.. (2016). Role of miR-223/paired box 6 signaling in temozolomide chemoresistance in glioblastoma multiforme cells. Molecular Medicine Reports. 15(2). 597–604. 18 indexed citations
16.
Li, Dazhi, et al.. (2016). MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein. Biochemical and Biophysical Research Communications. 481(3-4). 245–250. 27 indexed citations
17.
Qu, Qiang, Jian Qu, Zigui Chen, et al.. (2015). Common Variants of KCNJ10 Are Associated with Susceptibility and Anti-Epileptic Drug Resistance in Chinese Genetic Generalized Epilepsies. PLoS ONE. 10(4). e0124896–e0124896. 27 indexed citations
18.
Wan, Xin, Quan Cheng, Renjun Peng, et al.. (2014). ROCK1, a novel target of miR-145, promotes glioma cell invasion. Molecular Medicine Reports. 9(5). 1877–1882. 38 indexed citations
19.
Peng, Renjun, Bing Jiang, Zhiming Ma, et al.. (2013). Forced downregulation of RACK1 inhibits glioma development by suppressing Src/Akt signaling activity. Oncology Reports. 30(5). 2195–2202. 26 indexed citations
20.
Gao, Shan, Zigui Chen, Chen Shao, et al.. (2008). Reconsideration of the Phylogenetic Position of Frontonia-related Peniculia (Ciliophora, Protozoa) Inferred from the Small Subunit Ribosomal RNA Gene Sequences. Acta Protozoologica. 47(1). 47–54. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026